The first trial in the multidistrict litigation over Zoloft has been set for Nov. 9, which would trail the first state-court cases by about six months.
The MDL, which includes roughly 600 suits filed against Pfizer alleging that its antidepressant caused birth defects in babies born to mothers who took it while pregnant, was stayed for about the same amount of time, six months, while the court considered whether to let the plaintiffs offer a new expert after their first one was tossed.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
